XML 20 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Revenues        
Product revenue, net $ 23,125 $ 15,147 $ 45,022 $ 28,667
Revenue from Contract with Customer, Product and Service Product Product Product Product
Cost of sales $ 10,826 $ 6,251 $ 20,267 $ 10,314
Gross profit 12,299 8,896 24,755 18,353
Operating expenses        
Research and development 4,920 286 7,016 469
Selling and marketing 9,660 5,705 18,957 11,531
General and administrative 7,953 5,584 16,169 11,004
Acquisition related costs   1,312   1,312
Impairment of goodwill     19,453  
Amortization of intangible assets 1,060 1,584 2,153 3,169
Total operating expenses 23,593 14,471 63,748 27,485
Loss from operations (11,294) (5,575) (38,993) (9,132)
Other income (expense)        
Other income/(expense), net 20 (379) (20) (1,130)
Loss from contingent consideration (277) (3,313) (496) (3,311)
Loss on extinguishment of debt   (258)   (258)
Total other expense (257) (3,950) (516) (4,699)
Loss before income tax (11,551) (9,525) (39,509) (13,831)
Income tax benefit (3) 0 (110) 0
Net loss $ (11,548) $ (9,525) $ (39,399) $ (13,831)
Weighted average number of common shares outstanding - basic (in shares) 26,412,473 13,281,904 26,003,026 12,717,180
Weighted average number of common shares outstanding - diluted (in shares) 26,412,473 13,281,904 26,003,026 12,717,180
Basic net loss per common share (in dollars per share) $ (0.44) $ (0.72) $ (1.52) $ (1.09)
Diluted net loss per common share (in dollars per share) $ (0.44) $ (0.72) $ (1.52) $ (1.09)